Cargando…

Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists

BACKGROUND: In recent years, neurologists are noticing that evaluation of multiple sclerosis (MS) patients based on combining relapses, disability progression, and magnetic resonance imaging activity may be insufficient to adequately assess suboptimal responses to available therapy. Inclusion of qua...

Descripción completa

Detalles Bibliográficos
Autores principales: Ysrraelit, Maria C., Fiol, Marcela P., Gaitán, Maria I., Correale, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769192/
https://www.ncbi.nlm.nih.gov/pubmed/29375468
http://dx.doi.org/10.3389/fneur.2017.00729
_version_ 1783292852697038848
author Ysrraelit, Maria C.
Fiol, Marcela P.
Gaitán, Maria I.
Correale, Jorge
author_facet Ysrraelit, Maria C.
Fiol, Marcela P.
Gaitán, Maria I.
Correale, Jorge
author_sort Ysrraelit, Maria C.
collection PubMed
description BACKGROUND: In recent years, neurologists are noticing that evaluation of multiple sclerosis (MS) patients based on combining relapses, disability progression, and magnetic resonance imaging activity may be insufficient to adequately assess suboptimal responses to available therapy. Inclusion of quality of life (QoL) parameters may contribute to breach this gap. OBJECTIVE: To evaluate agreement levels between doctor and patient perception of QoL in MS. METHODS: A total of 700 MS patients and 300 neurologists were invited to participate in a cross-sectional study by answering an e-mail questionnaire. The survey collected information on demographical data and included the Short Form questionnaire (SF-36). After completing the questionnaire, patients were given a standard written description of each of the subdomains assessed by SF-36 and asked to identify which three were the most important determinants of their overall health-related QoL. RESULTS: A total of 135 neurologists and 380 MS patients responded the survey. Study population mean age was 42.1 ± 10.5 years, with 61% presenting relapsing-remitting MS. SF-36 results were physical function 68.4 ± 30, physical role limitation 56.8 ± 41.7, vitality 47.6 ± 21.4, pain 71.2 ± 26.1, social function 72.6 ± 28.6, emotional role limitation 63.2 ± 39.8, mental health 60 ± 14.1, and general health 55.8 ± 22. Doctors considered physical function (75%) and physical role limitation (70%) as the most important QoL determinants in MS, followed by emotional role limitation (52%). Patients however, assigned significantly different levels of importance to physical function (58%), and physical role limitation (46%) and considered vitality (52%) more important than their physicians (p < 0.001). Important to note, the results of SF-36 questionnaire were highly correlated with the perception gap between patients and neurologists (r = 0.89; p = 0.0004). CONCLUSION: Concerns on QoL in MS are different for patients and physicians. It is essential to enhance communication in order to better understand actual patient needs.
format Online
Article
Text
id pubmed-5769192
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-57691922018-01-26 Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists Ysrraelit, Maria C. Fiol, Marcela P. Gaitán, Maria I. Correale, Jorge Front Neurol Neuroscience BACKGROUND: In recent years, neurologists are noticing that evaluation of multiple sclerosis (MS) patients based on combining relapses, disability progression, and magnetic resonance imaging activity may be insufficient to adequately assess suboptimal responses to available therapy. Inclusion of quality of life (QoL) parameters may contribute to breach this gap. OBJECTIVE: To evaluate agreement levels between doctor and patient perception of QoL in MS. METHODS: A total of 700 MS patients and 300 neurologists were invited to participate in a cross-sectional study by answering an e-mail questionnaire. The survey collected information on demographical data and included the Short Form questionnaire (SF-36). After completing the questionnaire, patients were given a standard written description of each of the subdomains assessed by SF-36 and asked to identify which three were the most important determinants of their overall health-related QoL. RESULTS: A total of 135 neurologists and 380 MS patients responded the survey. Study population mean age was 42.1 ± 10.5 years, with 61% presenting relapsing-remitting MS. SF-36 results were physical function 68.4 ± 30, physical role limitation 56.8 ± 41.7, vitality 47.6 ± 21.4, pain 71.2 ± 26.1, social function 72.6 ± 28.6, emotional role limitation 63.2 ± 39.8, mental health 60 ± 14.1, and general health 55.8 ± 22. Doctors considered physical function (75%) and physical role limitation (70%) as the most important QoL determinants in MS, followed by emotional role limitation (52%). Patients however, assigned significantly different levels of importance to physical function (58%), and physical role limitation (46%) and considered vitality (52%) more important than their physicians (p < 0.001). Important to note, the results of SF-36 questionnaire were highly correlated with the perception gap between patients and neurologists (r = 0.89; p = 0.0004). CONCLUSION: Concerns on QoL in MS are different for patients and physicians. It is essential to enhance communication in order to better understand actual patient needs. Frontiers Media S.A. 2018-01-11 /pmc/articles/PMC5769192/ /pubmed/29375468 http://dx.doi.org/10.3389/fneur.2017.00729 Text en Copyright © 2018 Ysrraelit, Fiol, Gaitán and Correale. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Ysrraelit, Maria C.
Fiol, Marcela P.
Gaitán, Maria I.
Correale, Jorge
Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
title Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
title_full Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
title_fullStr Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
title_full_unstemmed Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
title_short Quality of Life Assessment in Multiple Sclerosis: Different Perception between Patients and Neurologists
title_sort quality of life assessment in multiple sclerosis: different perception between patients and neurologists
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5769192/
https://www.ncbi.nlm.nih.gov/pubmed/29375468
http://dx.doi.org/10.3389/fneur.2017.00729
work_keys_str_mv AT ysrraelitmariac qualityoflifeassessmentinmultiplesclerosisdifferentperceptionbetweenpatientsandneurologists
AT fiolmarcelap qualityoflifeassessmentinmultiplesclerosisdifferentperceptionbetweenpatientsandneurologists
AT gaitanmariai qualityoflifeassessmentinmultiplesclerosisdifferentperceptionbetweenpatientsandneurologists
AT correalejorge qualityoflifeassessmentinmultiplesclerosisdifferentperceptionbetweenpatientsandneurologists